'Novo Nordisk’s chief executive is preparing for a showdown next week with progressive firebrand Bernie Sanders over the high price of blockbuster diabetes and weight loss drugs, as Ozempic falls into the scope of US government price controls.'

https://www.ft.com/content/0bb0a4f8-ca72-4bc2-9d87-2dfff3567995